The application of recombinant DNA technology for genetic probing in epidemiology.

C. Caskey,R. Gibbs
DOI: https://doi.org/10.1146/ANNUREV.PU.10.050189.000331
IF: 21.87
Annual Review of Public Health
Abstract:Advances in recombinant DNA technology have greatly improved the pros­ pects for large scale genetic screening. The developments inclu�e better methods for obtaining DNA probes that are linked to disease traits �nd novel procedures for rapidly identifying DNA variation. The new methods are simple, reliable and can be automated. Because DNA is the common sub­ strate, a single format can be used to analyze a wide variety of different traits. Much of the very recent technological advancement is due to the develop­ ment of the polymerase chain reaction (PCR), a procedure for the in vitro amplification of nucleic acid sequences (69). In less than two years the method has found application in almost every facet of molecular biology. In the near future, the PCR will be used both in the elucidation of the molecular basis of genetic disease and in widespread screening for the disease alleles. Several groups are appropriate subjects for genetic screening by DNA methods. Prenatal and carrier screening will continue in families where risk for inherited disease has been established. Similarly, genetically isolated populations with high frequencies of particular traits will continue to be examined closely. However, the greatest increase in the application of DNA screening will be in testing the general population for recurrent alleles that cause or are associated with disease. Carriers of traits with simple modes of inheritance will be identified and individuals at risk for late onset disorders
Biology,Medicine
What problem does this paper attempt to address?